Cargando…
Antitumor Activity of ME2303, a Fluorine‐containing Anthracycline, against Human Tumors Implanted in Nude Mice
A fluorine‐containing anthracyctine, ME2303, given intravenously once a week for 4 weeks at the maximum tolerated dose showed better therapeutic effects against 2 gastric, 3 lung and 2 human breast tumor xenografts than did adriamycin (ADM) at the maximum tolerated dose. Among the tumors, ME2303 sho...
Autores principales: | Tsuruo, Takashi, Sato, Shigeo, Yusa, Keisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917819/ https://www.ncbi.nlm.nih.gov/pubmed/2507492 http://dx.doi.org/10.1111/j.1349-7006.1989.tb01697.x |
Ejemplares similares
-
Antitumor Activity and Metabolism of a New Anthracycline‐containing Fluorine (ME2303) in Lewis Lung Carcinoma‐bearing Mice
por: Tigo, Masaaki, et al.
Publicado: (1991) -
PB2303: THROMBOCYTOPENIA IN COVID-19 PATIENTS ON ECMO SUPPORT
por: Jones, C., et al.
Publicado: (2022) -
Antitumor Activity and Pharmacokinetics of a Morpholino‐anthracycline Derivative (KRN8602) against Human Breast Carcinoma Xenografts Serially Transplanted into Nude Mice
por: Kubota, Tetsuro, et al.
Publicado: (1990) -
Transduction of the Macrophage Colony‐stimulating Factor Gene into Human Multidrug Resistant Cancer Cells: Enhanced Therapeutic Efficacy of Monoclonal Anti‐P‐glycoprotein Antibody in Nude Mice
por: Sone, Saburo, et al.
Publicado: (1996) -
A comprehensive understanding of the biocontrol potential of Bacillus velezensis LM2303 against Fusarium head blight
por: Chen, Liang, et al.
Publicado: (2018)